Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05836961
Other study ID # BNP Study
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2023
Est. completion date September 2026

Study information

Verified date January 2023
Source Aga Khan University
Contact Dr Sajid Bashir Soofi
Phone +923002769398
Email sajid.soofi@aku.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the impact of Benazir Nashonuma Program (BNP) which includes specialized nutritious food (SNF) augmented with specific reproductive health interventions during pregnancy on proportion of low birthweight babies and stunting among children, in low income setting of Pakistan. The study aims to answer if: 1. Utilization of Benazir Nashonuma Program (BNP) among pregnant women is effective in reducing the proportion of low birthweight babies, compared to pregnant women who are not utilizing the program, among low income setting population. 2. Utilization of Benazir Nashonuma Program (BNP) is effective in reducing the proportion of stunting among children, compared to those not utilizing the program, among low income setting population. Participants who are enrolled in the Benazir Nashonuma Program (receiving intervention) and those who are not enrolled (not receiving intervention) will be followed throughout pregnancy till delivery. After delivery mother-baby dyad will be followed for a period of 12 months. Compliance of supplementation will be measured, and outcomes (low birthweight and stunting) observed throughout the follow up.


Description:

Malnutrition in Pakistan is a major and pervasive public health issue. Every four under five children in our country are reported to be stunted, with a mighty prevalence of 40.2% stunting as reported in the National Nutritional Survey of Pakistan 2018. Pakistan also shares one of the highest burden of low birthweight (LBW) where 19% babies in urban and 32% in rural are born with weight <2500 grams. LBW babies have a higher risk of death compared to full term babies and contributes to 60-80% of all neonatal deaths. The first 1000 days of life, the time from conception to 2 years of age, is a critical period, providing a window of opportunity for interventions to improve maternal and child nutrition and health outcomes including stunting and other nutritional markers. Availability and access to primary healthcare and nutrition services during pregnancy and the first two years of life can help prevent undernutrition and reduce infections in early life, helping reduce maternal and infant mortality, and preventing the lifelong and intergenerational consequences of malnutrition. Evidence-based nutrition interventions, especially the combination of BEP and small quantity lipid nutrient supplements have been shown to be effective in improving birth outcomes and reducing child stunting. BNP is a health and nutrition CCT programme, with the aim to address stunting in children under 23 months of age. The CCT and Specialized Nutritious Food (SNF) are provided to Benazir Income Support Programme (BISP) participating women during pregnancy and lactation up to 6 months and to children aged 6-23 months contingent on their participation in and adherence to BNP interventions. In addition to the programme components, the pre-existing standard of care interventions including antenatal and postnatal care, childhood immunizations, growth monitoring and behavior change communication (BCC) activities, i.e., awareness sessions on health, nutrition and hygiene. The primary study objectives are to assess the impact of intervention (BNP) on: - Proportion of babies born with low birthweight. - Prevalence of stunting among infants at 6 and 12 months of age The secondary objectives related to maternal outcomes are to assess the impact of intervention on: - Dietary diversity of women - Mean nutrient intake including energy in kilo calories. - Prevalence of iron deficiency anemia among lactating women. - Proportion of pregnant women using reproductive health services. The secondary objectives related to newborn and infant outcomes are to assess the impact of the intervention on: - Prevalence of wasting among infants at 6 and 12 months of age. - Incidence of anemia among infants at 6- and 12-months of age - Infant and child feeding practices among infants at 6 and 12 months of age. - Neurodevelopmental outcomes (cognitive, language and motor development) using Bayley Scales of Infant and Toddler Development (BSID-IV) at 6 months, and 12 months of age among children. Other objectives include following: - To measure receipt and utilization of BEP supplementation among pregnant and lactating women enrolled in BNP. - To measure receipt and utilization on BEP supplementation among children under 12 months of age enrolled in BNP - Household food insecurity status (using the Food Insecurity Experience Scale).


Recruitment information / eligibility

Status Recruiting
Enrollment 5500
Est. completion date September 2026
Est. primary completion date September 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria: Intervention arm: All pregnant women in their first or second trimester, who are enrolled in Benazir Nashonuma Program (BNP). Non-intervention arm: All pregnant women in their first or second trimester, who are not enrolled in Benazir Nashonuma Program (BNP). Exclusion Criteria: - Women who intend to migrate or relocate for more than 3 months during the study period will be excluded from the study. - Women in the non intervention group who are consuming specialized nutritious food (SNF) from any source at the time of enrollment will be excluded from the study.

Study Design


Intervention

Other:
Benazir Nashonuma Program (BNP)
Dietary supplement for pregnant women and lactating mothers during the first six months of lactation: Maamta is a 75-gram sachet made from peanut butter with 400 kcal of energy Dietary supplement for children aged 6-23 months: Wawamum is a lipid-based nutrient supplement consisting of skimmed milk powder, micronutrients, vegetable oil, roasted chickpeas and antioxidants. Wawamum covers the recommended daily dose of most micronutrients and 255 kcal of energy (1/4 of daily energy requirements for children in this age range) Conditional Cash Transfers (CCT): This includes stipends of PKR 2000 during pregnancy contingent on three antenatal care visits, consuming SNF, attending awareness sessions on health and nutrition, getting two doses of tetanus toxoid and institutional delivery. After delivery PKR 2000/- for boys and 2500/- for girls are paid as incentives conditioned on getting child's birth registered, routine immunization and consumption of SNF by the child from 6-23 months

Locations

Country Name City State
Pakistan Aga Khan Office Dadu Sindh

Sponsors (4)

Lead Sponsor Collaborator
Aga Khan University Bill and Melinda Gates Foundation, International Food Policy Research Institute, London School of Hygiene and Tropical Medicine

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of low birthweight Birth weight of less than 2500 g (up to and including 2499 g) within 48 hours of delivery Within 48-hours of delivery
Primary Prevalence of stunting Height-for-age =-2 SD of the WHO Child growth standards median At 6 months of age
Primary Prevalence of stunting Height-for-age =-2 SD of the WHO Child growth standards median At 12 months of age
Secondary Prevalence of wasting Weight-for-height =-2 SD of the WHO Child growth standards median. At 6 and 12 months of age
Secondary Prevalence of Iron deficiency anemia in pregnant women Hemoglobin levels below 11 g/dl, serum ferritin less than or equal to 30 ng/ml, mean corpuscular volume MCV below 95 fl will be considered diagnostic of iron deficiency anemia At 9th month on pregnancy
Secondary Prevalence of Iron deficiency anemia in infants Hemoglobin concentration of less than 11.0 g/dl and ferritin levels of less than 15 micrograms/L 2 point times: At 6 and 12 months of age
Secondary Number of antenatal care (ANC) visits during pregnancy Attending at least 8 ANC consultations in a health facility/clinic At delivery
Secondary Number of women who had an Institutional delivery Having delivered in a health facility At delivery
Secondary Number of women who had Skilled birth attendance Birth attended by a skilled health personnel At delivery
Secondary Number of women who had Postnatal care (PNC) check ups Receiving a postnatal health check while in a facility or at home within 6-weeks of postnatal period 3 months after delivery
Secondary Mean nutrient intake of energy in kilocalories of the pregnant woman Mean nutrient intake of energy in kilocalories using 24-hour recall. At 9th month of pregnancy
Secondary Prevalence of infants who were ever breastfed Number of infants who were breastfed at least once At 12 months of age
Secondary Prevalence of infants who had early initiation of breastfeeding Number of infants who were put to the breast within one hour of birth At 12 months of age
Secondary Prevalence of infants who were exclusively breastfed Number of of infants aged 0-5 months who were fed exclusively with breast milk during the previous day At 12 months of age
Secondary Prevalence of infants who consumed a minimum acceptable diet Number of infants 6-12 months of age who consumed a minimum acceptable diet during the previous day At 12 months of age
Secondary Prevalence of infants with minimum dietary diversity Number of infants 6-12 months of age who consumed foods and beverages from at least four out of eight defined food groups during the previous day At 12 months of age
Secondary Mean scores of Neurodevelopmental outcomes of the infant Neurodevelopmental outcomes of the children will be assessed using Bayley Scales of Infant and Toddler Development (BSID-IV). Mean scores will be reported for cognitive, language and motor development of the infant using Bayley's scales. Higher scores in the Bayley Scales indicate better outcomes At 12 months of age
Secondary Number of women consuming specialized nutritious food (SNF) Utilization of supplementation (SNF) by the woman during pregnancy and first 6 months of lactation after delivery At 6 months after delivery
Secondary Number of infants consuming specialized nutritious food (SNF) Utilization of supplementation (SNF) by the infant from 6-23 months of age At 12 months of age
See also
  Status Clinical Trial Phase
Recruiting NCT06027801 - Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity N/A
Completed NCT02282553 - Gastric Capsule Examination for Iron Deficiency Anaemia N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT04913649 - Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients Phase 4
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01307007 - Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Phase 2
Completed NCT00982007 - Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Phase 3
Completed NCT00198848 - Iron Supplementation Among Adolescent Girls in India N/A
Completed NCT01166451 - The Anemia Control Program: High or Low Iron Supplementation N/A
Recruiting NCT03893045 - A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects Phase 3
Recruiting NCT03817957 - Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency Phase 3
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Completed NCT03618914 - Anemia and Inflammation
Completed NCT03940430 - Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students Phase 2/Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Completed NCT03237065 - Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Phase 3
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department